Advertisement
U.S. Markets closed
S&P Futures
5,888.00 -4.50 (-0.08%) Dow Futures
43,042.00 -127.00 (-0.29%) Nasdaq Futures
20,520.00 -22.00 (-0.11%) Russell 2000 Futures
2,244.90 -1.30 (-0.06%) Crude Oil
72.24 +0.15 (+0.21%) Gold
2,752.70 -7.10 (-0.26%)
Aurora Cannabis Inc. (ACB.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Follow
At close: 04:00PM EDT
| Previous Close | 7.64 |
| Open | 7.56 |
| Bid | 8.42 x 0 |
| Ask | 8.43 x 0 |
| Day's Range | 7.56 - 8.62 |
| 52 Week Range | 3.84 - 12.85 |
| Volume | |
| Avg. Volume | 600,516 |
| Market Cap | 460.791M |
| Beta (5Y Monthly) | 2.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.63 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.50 |
ZacksAurora Cannabis Stock Rises Following Medical Cannabis Oil Launch
ACB and MedReleaf Australia launch premium medical cannabis oils, offering tailored cannabinoid formulations for patient care.
PR NewswireAurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia
Aurora Cannabis Inc., (NASDAQ: ACB) (TSX: ACB) – the Canadian based global leader in medical cannabis, in conjunction with MedReleaf Australia, is pleased to announce an enhanced product range of premium medical cannabis oil in Australia. This expansion reinforces Aurora's dedication to providing high-quality, innovative cannabis solutions to patients around the world. Now available for physicians to prescribe, the new cannabis oils include a variety of cannabinoid ratios to suit diverse patient
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.